Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 27, 2008Inflammatory Bowel DiseasesOpen Access

Effect of early immunomodulator use in moderate to severe pediatric Crohn disease

View Full Paper
Ask AI
Bookmark
Share

Authors

JPJaya PunatiApple (Israel)JMJames MarkowitzCohen Children's Medical CenterTLTrudy LererConnecticut Children's Medical Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Punati et al. (2008) studied this question.

synapsesocial.com/papers/6aa53d5807fb082b11dd40d9https://doi.org/10.1002/ibd.20412
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Azathioprine Maintains first remission in newly diagnosed pediatric Crohnʼs disease2006 · 42 citations
  2. 2IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases2000 · 29 citations
  3. 3Corticosteroids for maintenance of remission in Crohn's disease2003 · 224 citations
  4. 4EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE1986 · 202 citations